Samsara BioCapital »

Vtv Therapeutics Inc Cl A shares owned by Samsara BioCapital

Quarter-by-quarter ownership of Vtv Therapeutics Inc Cl A (VTVT) shares owned by Samsara BioCapital from 13F filings

Historical chart of Samsara BioCapital investment in Vtv Therapeutics Inc Cl A

Tip: Access up to 7 years of quarterly data

All positions including Vtv Therapeutics Inc Cl A held by Samsara BioCapital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vtv Therapeutics Inc Cl A by Samsara BioCapital

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.9M 207k 23.53
2023-12-31 $470k 41k 11.50

More positions owned by Samsara BioCapital

Scholar Rock Hldg Corp (SRRK)
Cargo Therapeutics (CRGX)
Mineralys Therapeutics (MLYS)
Neurogene (NGNE)
Nkarta (NKTX)
Arcellx Common Stock (ACLX)
Lenz Therapeutics
Lyra Therapeutics (LYRA)
Acelyrin (SLRN)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Jasper Therapeutics Com New (JSPR)
Zymeworks Del (ZYME)
Hillevax (HLVX)
Abivax Sa Sponsored Ads (ABVX)
Inozyme Pharma (INZY)

View all positions for Samsara BioCapital

Top funds holding Vtv Therapeutics Inc Cl A

Samsara BioCapital
Baker Bros. Advisors
Vanguard Group
UBS Group
BlackRock
Morgan Stanley
Planning Capital Management Corp
Tower Research Capital
Advisor Group Holdings
Royal Bank of Canada
Bank of America Corporation
Parallel Advisors
Wells Fargo & Company
Cornerstone Planning Group
Sunbelt Securities

View all funds holding Vtv Therapeutics Inc Cl A